<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NYSE:GMED (USA) Also Trade In: Germany

Globus Medical Inc $ 50.49 0.42 (0.84%)

Volume:
311,991
Avg Vol (1m):
550,329
Market Cap $:
5.00 Bil
Enterprise Value $:
4.76 Bil
P/E (TTM):
35.55
P/B:
4.00
Warning! GuruFocus has detected 2 Severe warning signs with GMED. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for GMED (Globus Medical) from 2012 to Oct 17 2019. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Globus Medical stock (GMED) PE ratio as of Oct 17 2019 is 35.55. More Details

Globus Medical PE Ratio (TTM) Chart

EMBED

Globus Medical PE Ratio (TTM) Historical Data

Total 1249
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Globus Medical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2019-10-1735.6 2019-08-1534.3
2019-10-1635.6 2019-08-1433.9
2019-10-1535.3 2019-08-1334.4
2019-10-1435.3 2019-08-1234.3
2019-10-1135.5 2019-08-0934.6
2019-10-1034.8 2019-08-0835.1
2019-10-0935.1 2019-08-0734.2
2019-10-0834.9 2019-08-0634.1
2019-10-0735.4 2019-08-0534.6
2019-10-0435.7 2019-08-0235.3
2019-10-0335.3 2019-08-0132.7
2019-10-0235.0 2019-07-3132.1
2019-10-0135.4 2019-07-3032.2
2019-09-3036.0 2019-07-2931.2
2019-09-2735.5 2019-07-2631.2
2019-09-2636.1 2019-07-2530.8
2019-09-2536.8 2019-07-2431.0
2019-09-2436.1 2019-07-2330.1
2019-09-2336.7 2019-07-2230.1
2019-09-2036.5 2019-07-1930.0
2019-09-1936.2 2019-07-1830.4
2019-09-1836.0 2019-07-1730.0
2019-09-1736.1 2019-07-1629.3
2019-09-1635.9 2019-07-1529.1
2019-09-1336.0 2019-07-1229.1
2019-09-1236.5 2019-07-1129.1
2019-09-1136.4 2019-07-1028.8
2019-09-1035.3 2019-07-0928.5
2019-09-0934.5 2019-07-0829.0
2019-09-0634.9 2019-07-0529.1
2019-09-0535.1 2019-07-0428.6
2019-09-0434.7 2019-07-0328.6
2019-09-0335.0 2019-07-0228.6
2019-09-0236.0 2019-07-0129.2
2019-08-3036.0 2019-06-2829.8
2019-08-2936.3 2019-06-2728.8
2019-08-2836.9 2019-06-2628.6
2019-08-2736.5 2019-06-2528.8
2019-08-2636.6 2019-06-2428.8
2019-08-2335.4 2019-06-2128.5
2019-08-2236.1 2019-06-2028.6
2019-08-2135.9 2019-06-1928.5
2019-08-2035.5 2019-06-1828.3
2019-08-1935.4 2019-06-1728.0
2019-08-1635.0 2019-06-1427.8

Globus Medical PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Medical Devices » Medical Devices NAICS : 339112 NAICS : 3841
Traded in other countries GM0N.Germany GMED.USA
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical is a medical device company that develops products for patients with musculoskeletal disorders. The firm's products are organized into two categories: innovative fusion and disruptive technologies. The innovative fusion products include fusion products that treat a variety of spinal disorders and can be used in several surgical applications. The disruptive technology products are used for applications such as minimally invasive surgery and new treatment alternatives, including motion preservation and regenerative biologic technologies. Globus Medical generates the vast majority of its revenue in the United States.